Original-Research: EasyMotionSkin Tec AG - von GBC AG
Einstufung von GBC AG zu EasyMotionSkin Tec AG
Unternehmen: EasyMotionSkin Tec AG
Anlass der Studie: Research Comment
Kursziel: 21.00 CHF / 19.28 EUR
Kursziel auf Sicht von: 31.12.2022
Analyst: Matthias Greiffenberger, Marcel Schaffer
Successful listing of EasyMotionSkin Tec AG on the m:access of the Munich
On 09.12.2021 EasyMotionSkin Tec AG was successfully listed on the m:access
of the Munich Stock Exchange. The initial share price is 14.50 EUR.
According to the management, no extensive capital market transactions are
planned in the near future.
The EasyMotionSkin Group consists of EasyMotionSkin Tec AG (EMS Tec AG) and
its wholly owned subsidiaries EasyMotionSkin Tec GmbH (EMS Tec GmbH) and
EMS GmbH. The Group primarily produces and distributes EMS training systems
consisting of a suit, a PowerBox and an app solution. EMS stands for
electro-muscle stimulation, which involves controlling and stimulating the
muscles by means of electrical impulses. With an EMS system, good results
can be achieved in the area of fitness and general health with
comparatively little training effort. There are already competitors in the
market with EMS studio chains or their own systems, but the EMS Group has a
patented solution that should be a clear competitive advantage: The dry
electrode and wireless training. With other EMS systems, the electrodes
must be moistened prior to the workout in order to make contact with the
body. The EasyMotionSkin product can be used without prior moistening. This
is on the one hand more hygienic and, on the other hand, more comfortable
for the user. The suit is a high-tech knitted product that withstands high
stresses and requires a knitting time of over six hours per suit in
production. In addition, an innovative woven-in and flexible cable harness
has been woven in to avoid the use of external cables.
According to the management, over 5,000 EMS systems have already been sold
in the last three years and the product has been steadily improved. Now the
company is to move into the growth phase and an extensive distribution
network is to be established in the DACH region.
The parent company EasyMotionSkin Tec AG was previously also used as an
investment vehicle by the owner (Christian Jäger, 97.7%) and thus business
areas outside the EasyMotionSkin Group were included in the company. This
legacy business was spun off at the beginning of 2021. Therefore,
comparability of the history with the forecast is only possible to a
limited extent. No consolidated group balance sheet has been prepared to
date either. The most informative period is the first half of 2021 with the
pure EasyMotionSkin business, here EMS Tec AG generated revenues of CHF
1.36 million, EMS Tec GmbH EUR 3.00 million and EMS GmbH EUR 0.80 million.
It is also important to note the supply chain in which EMS GmbH has the
products manufactured, resells them to EMS Tec AG and the latter in turn
resells them to EMS Tec GmbH. Respectively, net income of CHF 0.16 million
(EMS Tec AG), EUR 0.24 million (EMS Tec GmbH) and EUR -0.07 million (EMS
GmbH) was generated.
For the forecast we rely on a consolidated view and expect very dynamic
sales development. We based our sales forecast on the dynamic development
of the current market leader Body Street, which has reached 29,000 members
within four years. Our forecast is somewhat more conservative. The current
fiscal year 2021 is still impacted by the Covid-19 pandemic, so while
demand has increased, there have been supply shortages. As a result, we
expect revenues of CHF 4.25 million in 2021, followed by CHF 14.20 million
in 2022 and CHF 28.21 million in 2023, respectively. Strong growth is
expected to be achieved through broad network distribution, an optimized
online presence and studio partnerships. The company is also focusing on a
modern app solution that will enable users to compete with others as well
as be part of a community. In particular, the margin is to be increased via
economies of scale in purchasing and we forecast a net result of CHF -1.17
million in 2021, CHF 1.02 million in 2022 and CHF 2.88 million in 2023.
Based on our DCF model, we have determined a fair value per share of CHF
21.00 (EUR 19.28) and assign a BUY rating.
The link to the GBC IPO Study can be found here:
Die vollständige Analyse können Sie hier downloaden:
Kontakt für Rückfragen
0821 / 241133 0
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,6a,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:
Date (time) of completion: 09.12.2021 (10:45 am)
Date (time) of first distribution: 09.12.2021 (3:00 pm)
-------------------übermittelt durch die EQS Group AG.-------------------
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.